COVID-19 COVID-19 Vaccine mRNA Technology COVID-19 Vaccines Export Markets RSV Vaccine Covid Vaccine Valneva Flu Vaccine Regulatory Approval Respiratory Vaccines Respiratory Diseases Respiratory Syncytial Virus Human Metapneumovirus Virus-like Particles Horseshoe Crab Blood Covid Vaccines Flu Clinical Trials Coronavirus Vaccines Oxford-AstraZeneca Covid Vaccine AstraZeneca Technology MMR Vaccine mRNA Vaccines Public Perception Manufacturing Bio-pharmaceutical Research Public Health Policy Hepatitis B mRNA-based Vaccines Production Development Diabetes Protein Applications Nanomaterials Protein Therapeutics HPV Vaccine Regulatory Affairs Moderna Covid-19 Vaccine
Executives blame weaker COVID demand alongside pending patent losses, signaling a near-term reset toward pipeline investment.
